Simeon Kohl, Chief Executive Officer at Health Catalyst, Inc. (HCAT), bought 2,806,385 shares at $1.79 ($105K) on 2026-09-14, disclosed to the SEC on 2026-09-16.
Health Catalyst CEO Simeon Kohl purchased $105,439 worth of stock at $1.79 per share, marking the largest insider purchase in the company's history. This significant buy signals the CEO's confidence in the stock's value despite recent strategic shifts and market volatility.
The stock is trading at $1.72, down 1.15% over the last five days and 40.28% over the past year, placing it 52.42% below its 52-week high of $3.62.
Q2 2026 earnings on August 7, 2026 showed revenue of $70.49 million (down 12.7% YoY) and a weak Q3 revenue forecast of $55.5 million, which is 10.7% below estimates.
The company faces significant revenue headwinds, having cycled through three CEOs in eight months and recently divesting its Vitalware business to focus on its AI pivot.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,747,385 | $0 | 0.0% |
| 2 | $1.79 | 59,000 | $105K | 100.0% |
| Total | $0.04 avg | 2,806,385 | $105K | 100% |
| Filing → |
| PFMT | SELL | 2019-02-12 | $6K | — | Filing → |
| PFMT | SELL | 2019-02-08 | $678 | — | Filing → |
| PFMT | SELL | 2019-02-05 | $13K | — | Filing → |